Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04182048
Other study ID # HM102001
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date September 14, 2019
Est. completion date July 2022

Study information

Verified date April 2022
Source HealthMode Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A remote study to find out if a mobile phone application (HealthMode Stool) can serve as a useful tool to track and characterize daily bowel movements. The application provides participants with a single place to record their bowel movements either as a part of their general health self-monitoring, or because they may be dealing with a bowel movement condition. The minimal study duration is 1 month, and participants can continue using the application up to 2 years.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 843
Est. completion date July 2022
Est. primary completion date July 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Females and males over 18 years old - Willing to use their own/personal mobile phone (iPhone 6 or higher, running iOS 11 or higher) for participation - Willing to share demographic data with the sponsor of the study - Willing to follow app use instructions during the course of the study - Willing to log the bowel movement events on a daily basis with manual input of additional characteristics - Willing to complete survey instruments as described in study procedures - Willing to provide electronic informed consent - Able to read and understand the english language well enough to complete electronic informed consent Exclusion Criteria: - New to HealthMode Stool application: - No additional exclusion criteria. OR - Current HealthMode Stool User: - Is an active participant in any other study using HealthMode Stool app in its protocol.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Virtual Facility Bronx New York

Sponsors (1)

Lead Sponsor Collaborator
HealthMode Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Sensitivity and specificity of models for automatic determination of bowel movement characteristics Receiver Operating Characteristic of created mathematical models 28 days
Primary Dataset completeness Aiming for 90% in two dataset completeness aspects: bowel movement entry days and bowel movement characteristics completeness. 28 days
Secondary Daily bowel movement characteristics and fluctuation Measured as category frequency and fluctuations in Bristol Stool Scale items 28 days
Secondary Daily bowel movement characteristics and fluctuation Measured as changes in Gastro-intestinal Symptom Rating Scale score. The score ranges from 15 to 105, lower score indicating a better outcome 28 days
Secondary Daily bowel movement characteristics and fluctuation Measured as changes in Visceral Sensitivity Index score. The score ranges from 15 to 90, lower score indicating a worse outcome 28 days
Secondary Usability of the application Level of usability of the solution by patients by means of a Standard Usability Questionnaire score. The score ranges from 10 to 50, higher score indicating a better usability. 28 days
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1